First-Line Diagnostic Approach for Suspected PE in High-Risk Patients
For high-risk patients with suspected pulmonary embolism (PE), CT pulmonary angiography (CTPA) should be the first-line diagnostic test rather than D-dimer testing. 1, 2
Diagnostic Algorithm for Suspected PE
Step 1: Risk Stratification
- Use validated clinical prediction tools (Wells score or Geneva score) to assess pretest probability 2
- Evaluate for key symptoms: dyspnea, chest pain, tachycardia, tachypnea, and hypoxemia
Step 2: Diagnostic Testing Based on Risk
For high-risk patients:
For low to intermediate-risk patients:
Rationale for CTPA as First-Line in High-Risk Patients
- Diagnostic accuracy: CTPA has established high sensitivity and specificity for PE diagnosis 1, 3
- Clinical efficiency: Direct CTPA in high-risk patients avoids delays in diagnosis
- Comprehensive evaluation: CTPA can identify alternative diagnoses when PE is not present 1
Alternative Diagnostic Approaches
- Lower-extremity venous ultrasonography: Consider for patients with multiple prior CT scans or with lower extremity symptoms 2
- V/Q scanning: Option for patients with contraindications to CTPA (renal insufficiency, contrast allergy) 2
- Note: A normal perfusion scan effectively excludes PE 2
Important Caveats
- D-dimer testing has limited utility in high-risk patients due to high false positive rates
- Negative CTPA is highly reliable for excluding clinically significant PE 3
- The accuracy of older CT technology was more limited, with sensitivities ranging from 0.68-0.81 depending on the level of pulmonary arteries examined 4
- Modern multidetector CT technology has significantly improved diagnostic accuracy compared to older studies 5
Common Pitfalls to Avoid
- Relying on D-dimer alone in high-risk patients can lead to missed diagnoses
- Overreliance on CT scans in low-risk patients with negative D-dimer results is unnecessary 1, 2
- Failure to consider radiation exposure risks in patients requiring multiple imaging studies 2
By following this algorithm, clinicians can efficiently diagnose or exclude PE while minimizing unnecessary testing and radiation exposure.